World's leading clinical conference on bone, joint and muscle health
Programme
Saturday April 12 th - CEST Timezone
08:00 - 09:00
Auditorium B
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR4
Patient-centred approach to Sarcopenia: from standard of care to digital technologies
Chairpersons: Maria Luisa Brandi, Giovanni Iolascon
Chairpersons: Maria Luisa Brandi, Giovanni Iolascon
08:00
MR4
The global burden of Sarcopenia
08:00
MR4
Multimodal exercise and nutrition: the pillars of Sarcopenia treatment
08:00
MR4
Digital Technologies in Sarcopenia Treatment: the right therapy for the right patient
08:00
MR4
Closing remarks
08:00
MR1
Comprehensive Care for Pediatric Bone Fragility
Chairperson: Leith Zakraoui
Chairperson: Leith Zakraoui
08:00
MR1
Bone fragility and osteoporosis in children and adolescents: when and how to diagnose it?
08:00
MR1
Bone fragility and osteoporosis in children and adolescents: when and how to treat it?
08:00
MR1
Discussion / Q&A
08:00
MR2
Osteoporosis and Complex Regional Pain Syndrome (CRPS)
Chairperson: Ayșe A. Küçükdeveci
Chairperson: Ayșe A. Küçükdeveci
08:00
MR2
A significant problem following osteoporotic fractures: Complex Regional Pain Syndrome
08:00
MR2
Can we treat CRPS by pharmacological agents?
08:00
MR2
The role of non-pharmacological approaches in the management of CRPS
08:00
MR3
The evolution of post fracture care services in LATAM pre and post CTF mentorship programme
Chairpersons: Osvaldo Daniel Messina, Willem Lems
Chairpersons: Osvaldo Daniel Messina, Willem Lems
08:00
MR3
Qualitative and quantitative change in FLS/PFC in LATAM. An overview
08:00
MR3
Key Performance Indicators of PFC/FLS in LATAM. Expected outcomes based on BC in Mexico and Colombia
08:00
MR3
Successful country specific strategies to improve and increase the number of FLS
08:00
MR3
Challenges ahead. Gathering key data for monitoring performance and improving quality of PFC/FLS. Country specific dataset. Experience of the Argentine Hip Fracture Registry: Pasos® Program
08:00
MR8
Pregnancy and lactation, a challenge for the Bone and Muscle Health
Chairperson: Yasser El Miedany
Chairperson: Yasser El Miedany
08:00
MR8
Pregnancy, and lactation a challenge for the skeleton
08:00
MR8
Movement recommendations for Pregnant and lactating women
08:00
MR10
Abdominal aortic calcification and musculoskeletal health
Chairperson: Peter R. Ebeling
Chairperson: Peter R. Ebeling
08:00
MR10
Abdominal aortic calcification, what it is and why it is important
08:00
MR10
Abdominal aortic calcification and musculoskeletal outcomes
08:00
MR10
Abdominal aortic calcification as a novel risk factor for falls and fractures in routine clinical practice
08:00
MR10
Provision of abdominal aortic calcification results to patients
08:00 - 09:00
MR5
ISGE-ESCEO joint Symposium Session: The gynecologist and bone: A tale of woman's health
Chairpersons: Andrea Riccardo Genazzani, Şansin Tüzün
Chairpersons: Andrea Riccardo Genazzani, Şansin Tüzün
08:00
MR5
The role of sex steroids in the health of the musculoskeletal system: a lifetime journey
08:00
MR5
When the ovaries fail early: protecting the bone
08:00
MR5
Menopause and the bone: a matter for gynecologists
08:00 - 09:00
MR6
ESCEO Symposium: Treatment of osteoporosis and osteoarthritis in the oldest old
Chairpersons: Andrea Laslop, René Rizzoli
Chairpersons: Andrea Laslop, René Rizzoli
08:00
MR6
Specific considerations for the management of osteoporosis in the oldest old
08:00
MR6
Specific considerations for the management of osteoarthritis in the oldest old
08:00
MR6
Discussion leader
08:00 - 09:00
MR7
DVO-ESCEO Symposium: Special aspects of osteoporosis
Chairpersons: Ralf Schmidmaier, Olivier Bruyère
Chairpersons: Ralf Schmidmaier, Olivier Bruyère
08:00
MR7
The role of bone anabolic treatment in the geriatric population
08:00
MR7
Management of pregnancy associated osteoporosis
08:00
MR7
Osteonecrosis of the jaw: novel insights and current status
08:00
MR7
Dealing with atypical femur fractures
09:00 - 10:30
Auditorium A
Scientific Session IV
Chairpersons: Manju Chandran, Peter R. Ebeling
Chairpersons: Manju Chandran, Peter R. Ebeling
09:00
Auditorium A
Plenary Lecture
Advances in personalized fracture risk assessment: FRAX and beyond
Advances in personalized fracture risk assessment: FRAX and beyond
09:30
Auditorium A
Oral communications selected from abstracts
OC19: RELATIONSHIP BETWEEN COMORBIDITY, PHYSICAL ACTIVITY AND FRAILTY DIFFER ACCORDING TO EDUCATIONAL ATTAINMENT: FINDINGS FROM THE SOUTHAMPTON LONGITUDINAL STUDY OF AGEING (SALSA)
OC19: RELATIONSHIP BETWEEN COMORBIDITY, PHYSICAL ACTIVITY AND FRAILTY DIFFER ACCORDING TO EDUCATIONAL ATTAINMENT: FINDINGS FROM THE SOUTHAMPTON LONGITUDINAL STUDY OF AGEING (SALSA)
09:40
Auditorium A
Oral communications selected from abstracts
OC20: RELATIONSHIPS BETWEEN CHANGE IN SEX HORMONES WITH CHANGE IN MEASURES OF SARCOPENIA: A LONGITUDINAL STUDY IN COMMUNITY DWELLING OLDER MEN
OC20: RELATIONSHIPS BETWEEN CHANGE IN SEX HORMONES WITH CHANGE IN MEASURES OF SARCOPENIA: A LONGITUDINAL STUDY IN COMMUNITY DWELLING OLDER MEN
09:50
Auditorium A
Oral communications selected from abstracts
OC21: OSTEOSARCOPENIA AS A RISK FACTOR FOR DEPRESSION: LONGITUDINAL FINDINGS FROM THE SHARE STUDY
OC21: OSTEOSARCOPENIA AS A RISK FACTOR FOR DEPRESSION: LONGITUDINAL FINDINGS FROM THE SHARE STUDY
10:00
Auditorium A
Oral communications selected from abstracts
OC22: PSYCHOMETRIC PROPERTIES OF THE SARQOL QUESTIONNAIRE: A SYSTEMATIC REVIEW AND META-ANALYSIS
OC22: PSYCHOMETRIC PROPERTIES OF THE SARQOL QUESTIONNAIRE: A SYSTEMATIC REVIEW AND META-ANALYSIS
10:10
Auditorium A
Oral communications selected from abstracts
OC23: BIOLOGICAL AGE-ACCELERATION ASSOCIATIONS WITH GRIP STRENGTH LEVEL AND LONGITUDINAL CHANGE: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
OC23: BIOLOGICAL AGE-ACCELERATION ASSOCIATIONS WITH GRIP STRENGTH LEVEL AND LONGITUDINAL CHANGE: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:15
Auditorium A
Scientific Session V
Chairpersons: Şansin Tüzün, Ambrish Mithal
Chairpersons: Şansin Tüzün, Ambrish Mithal
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award
10:35
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Presentation of the 2025 ESCEO-Aging Clinical and Experimental Research Award
10:45
Auditorium A
Plenary Lecture
MicroRNAs: novel risk predictors in musculoskeletal disease?
MicroRNAs: novel risk predictors in musculoskeletal disease?
11:15
Auditorium A
Oral communications selected from abstracts
OC24: TREATMENT-RELATED CHANGES IN TOTAL HIP BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION FOR TRIALS WITH ACTIVE CONTROL AND SEQUENTIAL THERAPY: THE FNIH-ASBMR-SABRE PROJECT
OC24: TREATMENT-RELATED CHANGES IN TOTAL HIP BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION FOR TRIALS WITH ACTIVE CONTROL AND SEQUENTIAL THERAPY: THE FNIH-ASBMR-SABRE PROJECT
11:25
Auditorium A
Oral communications selected from abstracts
OC25: THE PREVALENCE OF VERTEBRAL FRACTURES AND ASSOCIATED FACTORS IN THE GAMBIA, ZIMBABWE AND SOUTH AFRICA
OC25: THE PREVALENCE OF VERTEBRAL FRACTURES AND ASSOCIATED FACTORS IN THE GAMBIA, ZIMBABWE AND SOUTH AFRICA
11:35
Auditorium A
Oral communications selected from abstracts
OC26: ENHANCING FRACTURE RISK PREDICTION: A COHORT-SPECIFIC MODEL INTEGRATING FRAXPLUS® VARIABLES FOR IMPROVED ACCURACY AND RECLASSIFICATION
OC26: ENHANCING FRACTURE RISK PREDICTION: A COHORT-SPECIFIC MODEL INTEGRATING FRAXPLUS® VARIABLES FOR IMPROVED ACCURACY AND RECLASSIFICATION
11:45
Auditorium A
Oral communications selected from abstracts
OC27: ENGAGEMENT WITH AND TOLERABILITY OF AUGMENTED REALITY (AR) EXERGAMES AMONG OLDER WOMEN WITH OSTEOPOROSIS: RESULTS FROM A CLINICAL TRIAL
OC27: ENGAGEMENT WITH AND TOLERABILITY OF AUGMENTED REALITY (AR) EXERGAMES AMONG OLDER WOMEN WITH OSTEOPOROSIS: RESULTS FROM A CLINICAL TRIAL
11:55
Auditorium A
Oral communications selected from abstracts
OC28: EFFECTS OF ANTIDIABETETIC TREATMENTS ON FRACTURE RISK
OC28: EFFECTS OF ANTIDIABETETIC TREATMENTS ON FRACTURE RISK
12:05
Auditorium A
Oral communications selected from abstracts
OC29: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
OC29: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
12:15 - 13:45
Auditorium A
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
12:15 - 13:45
Auditorium B
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
14:00 - 15:00
Poster Viewing Session II
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Biochemical markers of bone turnover: when and which?
14:00
MR1
Vaccination and musculoskeletal disorders
14:00
MR2
Osteoporosis management in transgender patients
14:00
MR3
Is there a role for SYSADOAs in the management of osteoarthritis ?
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elizabeth M. Curtis
Chairperson: Elizabeth M. Curtis
14:00
Podium
OP11 - P1425: EVALUATING THE PRAGMATISM OF SARCOPENIA CLINICAL TRIALS USING PRECIS-2: A SYSTEMATIC REVIEW
14:06
Podium
OP12 - P1387: REFINING EARLY DETECTION OF LOW BONE MINERAL DENSITY: A DEEP LEARNING MODEL FOR OSTEOPENIA SCREENING USING CHEST RADIOGRAPHS
14:12
Podium
OP13 - P147 CALCIUM ISOTOPE RATIOS IN SERUM INFORM ON SKELETAL CALCIUM BALANCE IN PATIENTS ON DIALYSIS
14:18
Podium
OP14 - P1025: ASSOCIATIONS BETWEEN BODY COMPOSITION, EXERCISE, DIET, SHORT-CHAIN FATTY ACIDS, AND BONE LOSS IN EARLY POSTMENOPAUSAL WOMEN
14:24
Podium
OP15 - P144: CALCIUM ISOTOPES AS A NOVEL BIOMARKER FOR VASCULAR CALCIFICATION IN CKD: IMPLICATIONS FOR OSTEOPOROSIS MANAGEMENT
14:30
Podium
OP16 - P776: FILLING GAPS IN TELEREHABILITATION: VALIDATING REMOTE SYNCHRONOUS AND ASYNCHRONOUS ASSESSMENTS OF PERFORMANCE-BASED OUTCOMES
14:36
Podium
OP17 - P736: THE FIRST COMPARISON OF HIP FRACTURE INCIDENCE ACROSS 4 COUNTRIES IN AFRICA
14:42
Podium
OP18 - P498: DIFFERENTIAL ANALYSIS OF LUMBAR SPINE BONE MINERAL DENSITY AND TRABECULAR BONE SCORE IN HYPOPHOSPHATASIA PATIENTS WITH BIALLELIC VS MONOALLELIC ALPL GENOTYPE
14:48
Podium
OP19 - P538: WHICH THRESHOLD VALUES OF CROSSLAPS TO TARGET TO PREVENT BONE LOSS AT 1 AND 2 YEARS AFTER DENOSUMAB DISCONTINUATION. THE REOLAUS STUDY
14:54
Podium
OP20 - P1044: ABALOPARATIDE INCREASES DISTAL FEMUR BMD POST TOTAL KNEE ARTHROPLASTY
14:00 - 15:00
MR10
Educational Lecture
14:00
MR10
Osteoporosis in inflammatory rheumatic musculoskeletal diseases (iRMDs)
14:00 - 15:00
MR5
EuGMS-ESCEO symposium: Fragility fractures: One size fits all?
Chairpersons: Nathalie van der Velde, Alvaro Casas Herrero
Chairpersons: Nathalie van der Velde, Alvaro Casas Herrero
14:00
MR5
Preventing fragility fractures in the oldest old: special considerations?
14:00
MR5
Preventing fragility fractures: similarities and differences in approaches between LMICs and Europe
14:00
MR5
Integrating fall risk prevention within fracture management: practical steps to optimize implementation
14:00 - 15:00
MR6
ESCEO-OARSI Joint Symposium: Early knee osteoarthritis: Classification criteria for research and diagnostic criteria for clinical use
Chairpersons: Jean-Yves Reginster, Martin Englund
Chairpersons: Jean-Yves Reginster, Martin Englund
14:00
MR6
Classification criteria of early-stage symptomatic knee osteoarthritis: updates of the OARSI initiative
14:00
MR6
Diagnostic criteria for early knee osteoarthritis: Opportunities and challenges
14:00 - 15:00
MR7
ESCEO Symposium: Novel approaches to the stratified management of knee osteoarthritis: State of the art
Chairpersons: Ali Mobasheri, Roland Chapurlat
Chairpersons: Ali Mobasheri, Roland Chapurlat
14:00
MR7
The delineation of endotype and phenotype to identify the patients with knee osteoarthritis who should be treated
14:00
MR7
The role of biomarkers (imaging, biological) to identify the patients with knee osteoarthritis who should be treated
14:00
MR7
Discussion leader
14:00 - 15:00
MR8
Educational Lecture
14:00
MR8
Biosimilars in osteoporosis management
15:00 - 16:45
MR5
Committee of Scientific Advisors Special Session: Future opportunities in the management of osteoporosis
Chairpersons: Eugene McCloskey, Etienne Cavalier
Chairpersons: Eugene McCloskey, Etienne Cavalier
15:00
MR5
Barriers and solutions for global access to osteoporosis management
15:00
MR5
Approaches to risk-based Population Screening: Insights from the ROSE study and FREM development in Denmark
15:00
MR5
The Fact and Fiction of AI in Osteoporosis
15:00 - 17:00
Auditorium A
Scientific Session VI
Chairpersons: Patricia Clark, Radmila Matijevic
Chairpersons: Patricia Clark, Radmila Matijevic
15:00
Auditorium A
Plenary Lecture
Novel concepts: assessment of intrinsic capacity
Novel concepts: assessment of intrinsic capacity
15:30
Auditorium A
Oral communications selected from abstracts
OC30: EFFECTS OF A REMOTELY-DELIVERED FUNCTIONAL RESISTANCE AND IMPACT TRAINING PROGRAM VERSUS WALKING ON PHYSICAL FUNCTION IN OLDER ADULTS WITH OBESITY UNDERGOING CALORIC RESTRICTION: A 6-MONTH RANDOMISED CONTROLLED TRIAL
OC30: EFFECTS OF A REMOTELY-DELIVERED FUNCTIONAL RESISTANCE AND IMPACT TRAINING PROGRAM VERSUS WALKING ON PHYSICAL FUNCTION IN OLDER ADULTS WITH OBESITY UNDERGOING CALORIC RESTRICTION: A 6-MONTH RANDOMISED CONTROLLED TRIAL
15:40
Auditorium A
Oral communications selected from abstracts
OC31: MATERNAL BONE MINERAL DENSITY AT 4 YEARS POST-DELIVERY IS NOT AFFECTED BY PREGNANCY VITAMIN D SUPPLEMENTATION
OC31: MATERNAL BONE MINERAL DENSITY AT 4 YEARS POST-DELIVERY IS NOT AFFECTED BY PREGNANCY VITAMIN D SUPPLEMENTATION
15:50
Auditorium A
Oral communications selected from abstracts
OC32: USING PROBIOTICS TO SUPPORT BONE HEALTH IN POSTMENOPAUSAL WOMEN: A RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED, MULTI-CENTRE STUDY
OC32: USING PROBIOTICS TO SUPPORT BONE HEALTH IN POSTMENOPAUSAL WOMEN: A RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED, MULTI-CENTRE STUDY
16:00
Auditorium A
Oral communications selected from abstracts
OC33: RELATIONSHIPS BETWEEN MICRORNAS AND CORTICAL BONE IN CHRONIC KIDNEY DISEASE
OC33: RELATIONSHIPS BETWEEN MICRORNAS AND CORTICAL BONE IN CHRONIC KIDNEY DISEASE
16:10
Auditorium A
Oral communications selected from abstracts
OC34: FRAGILITY FRACTURES MANAGEMENT IN PREGNANCY BY REMS TECHNOLOGY: THE PREGNANCY OSTEOPOROSIS INITIATIVE (POI)
OC34: FRAGILITY FRACTURES MANAGEMENT IN PREGNANCY BY REMS TECHNOLOGY: THE PREGNANCY OSTEOPOROSIS INITIATIVE (POI)
16:20
Auditorium A
Oral communications selected from abstracts
OC35: INTERACTIONS BETWEEN CALCIUM AND PROTEIN INTAKES, AND OSTEOPOROSIS MEDICATIONS ON HIP BONE STRENGTH: AN OBSERVATIONAL STUDY IN OLDER WOMEN
OC35: INTERACTIONS BETWEEN CALCIUM AND PROTEIN INTAKES, AND OSTEOPOROSIS MEDICATIONS ON HIP BONE STRENGTH: AN OBSERVATIONAL STUDY IN OLDER WOMEN
16:30
Auditorium A
Plenary Lecture
Osteoimmunology: a legacy discipline?
Osteoimmunology: a legacy discipline?
17:00 - 18:00
Auditorium B
Educational Lecture
17:00
Auditorium B
Pregnancy - and lactation-related osteoporosis
17:00 - 18:00
Non-Sponsored Symposia
17:00
MR1
Bone, Muscle and Fat interractions in neurodisabled persons
Chairperson: Ifigenia Kostoglou-Athanassiou
Chairperson: Ifigenia Kostoglou-Athanassiou
17:00
MR1
Introduction in bone, muscle and fat interactions
17:00
MR1
(Osteo)Sarcopenia and sarcopenic obesity in neurodisabled individuals
17:00
MR1
Sarcopenia in Hemiplegia and Stroke
17:00
MR1
Discussion in bone, muscle and fat interactions
17:00
MR2
From bone metastasis to osteoporosis - Joint IOF and CABS Symposium (Cancer and Bone Society)
Chairpersons: Patricia Juarez-Camacho, Peyman Hadji
Chairpersons: Patricia Juarez-Camacho, Peyman Hadji
17:00
MR2
Decoding skeletal complications in bone metastases
17:00
MR2
Treatment of bone metastasis – state of the art 2025
17:00
MR2
CTIBL – size of the problem and treatment options?
17:00
MR3
The Latest in Artificial Intelligence in Osteoporosis: From Large Language Models to Computer Vision
Chairperson: Nicholas Fuggle
Chairperson: Nicholas Fuggle
17:00
MR3
What are ‘A Large Language ModeIs’ and how can they be deployed in osteoporosis?
17:00
MR3
Health Equity considerations when using AI in Clinical Practice
17:00
MR3
AI for vertebral fracture screening: A UK perspective – An update from the ADOPT study
17:00
MR4
Improving and Enhancing DXA Practices; A joint symposium with ISCD and IOF
Chairpersons: Nicholas C. Harvey, William D. Leslie
Chairpersons: Nicholas C. Harvey, William D. Leslie
17:00
MR4
DXA Quality, Common Errors and Clinical Impact
17:00
MR4
The ABCs of DXA and How to Improve fractures
17:00
MR4
Expanding DXA Functionality to Enhance Clinical Care
17:00
MR5
The challenge of oral health in patients with osteoporosis: A pragmatic approach
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
17:00
MR5
Introduction: Oral health and bone health. A quotidian dilemma?
17:00
MR5
The overall impact of oral health in the elderly
17:00
MR5
Osteoporotic fractures and MRONJ: Sobering statistics
17:00
MR5
Improving oral screening: the Oral Health Assessment Tool
17:00
MR5
Discussion: Whose task is it to identify oral health?
17:00
MR6
Conclusions
17:00
MR6
Skeletal fragility: The role of vitamin D and K in CKD patients
Chairpersons: Maria Fusaro, Thomas L. Nickolas
Chairpersons: Maria Fusaro, Thomas L. Nickolas
17:00
MR6
Vitamin D: from native to active form in CKD-associated osteoporosis
17:00
MR6
Vitamin K: instructions for use in skeletal fragility
17:00
MR6
The Statistician in detecting fraud and negligence in clinical trials
17:00
MR6
Vitamin D in Skeletal Fragility: Clinical Case
17:00
MR6
Discussion
17:00
MR7
Breaking Barriers and Advancing Bone Health for People with Intellectual Disability
Chairperson: Éilish Burke
Chairperson: Éilish Burke
17:00
MR7
The Silent Epidemic of Osteoporosis among Adults with Intellectual Disabilities
17:00
MR7
Exploring Dietary Deficiencies in Adults with Intellectual Disabilities Contributing to Poor Bone Health
17:00
MR7
Sedentary Behaviour and its Implications for the Bone Health of those with Intellectual Disability
17:00
MR7
Innovative Solutions: The Echolight Rems Device for Accessible Bone Health Screening for Adults With Intellectual Disability
17:00
MR8
New horizons in sarcopenia: From pediatric reference values to emerging therapeutic advances
Chairpersons: Gulistan Bahat, Radmila Matijevic
Chairpersons: Gulistan Bahat, Radmila Matijevic
17:00
MR8
Recognizing and managing Sarcopenia in Children: Reference muscle mass values from a European cohort
17:00
MR8
Molecular Insights, Pathways and Candidates for Novel Interventions in Sarcopenia